These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 26940094

  • 1. Urinary Soluble CD163 in Active Renal Vasculitis.
    O'Reilly VP, Wong L, Kennedy C, Elliot LA, O'Meachair S, Coughlan AM, O'Brien EC, Ryan MM, Sandoval D, Connolly E, Dekkema GJ, Lau J, Abdulahad WH, Sanders JS, Heeringa P, Buckley C, O'Brien C, Finn S, Cohen CD, Lindemeyer MT, Hickey FB, O'Hara PV, Feighery C, Moran SM, Mellotte G, Clarkson MR, Dorman AJ, Murray PT, Little MA.
    J Am Soc Nephrol; 2016 Sep; 27(9):2906-16. PubMed ID: 26940094
    [Abstract] [Full Text] [Related]

  • 2. Urinary and serum soluble CD25 complements urinary soluble CD163 to detect active renal anti-neutrophil cytoplasmic autoantibody-associated vasculitis: a cohort study.
    Dekkema GJ, Abdulahad WH, Bijma T, Moran SM, Ryan L, Little MA, Stegeman CA, Heeringa P, Sanders JF.
    Nephrol Dial Transplant; 2019 Feb 01; 34(2):234-242. PubMed ID: 29506265
    [Abstract] [Full Text] [Related]

  • 3. Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis.
    Endo N, Tsuboi N, Furuhashi K, Shi Y, Du Q, Abe T, Hori M, Imaizumi T, Kim H, Katsuno T, Ozaki T, Kosugi T, Matsuo S, Maruyama S.
    Nephrol Dial Transplant; 2016 Dec 01; 31(12):2023-2033. PubMed ID: 27242373
    [Abstract] [Full Text] [Related]

  • 4. Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Moran SM, Monach PA, Zgaga L, Cuthbertson D, Carette S, Khalidi NA, Koening CL, Langford CA, McAlear CA, Moreland L, Pagnoux C, Seo P, Specks U, Sreih A, Wyse J, Ytterberg SR, Merkel PA, Little MA, Vasculitis Clinical Research Consortium.
    Nephrol Dial Transplant; 2020 Feb 01; 35(2):283-291. PubMed ID: 30380100
    [Abstract] [Full Text] [Related]

  • 5. The Clinical Application of Urine Soluble CD163 in ANCA-Associated Vasculitis.
    Moran SM, Scott J, Clarkson MR, Conlon N, Dunne J, Griffin MD, Griffin TP, Groarke E, Holian J, Judge C, Wyse J, McLoughlin K, O'Hara PV, Kretzler M, Little MA, Nephrotic Syndrome Study Network (NEPTUNE).
    J Am Soc Nephrol; 2021 Nov 01; 32(11):2920-2932. PubMed ID: 34518279
    [Abstract] [Full Text] [Related]

  • 6. Urinary Soluble CD163 Levels Predict IgA Nephropathy Remission Status.
    Gong S, Jin S, Li Y, Jiang W, Zhang Z, Shen Z, Wang J, Zhou H, Liu X, Xu X, Ding X, Shi Y, Liu H.
    Front Immunol; 2021 Nov 01; 12():769802. PubMed ID: 35003086
    [Abstract] [Full Text] [Related]

  • 7. Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages.
    Zhang T, Li H, Vanarsa K, Gidley G, Mok CC, Petri M, Saxena R, Mohan C.
    Front Immunol; 2020 Nov 01; 11():671. PubMed ID: 32351512
    [Abstract] [Full Text] [Related]

  • 8. Urinary Soluble CD163 and Disease Activity in Biopsy-Proven ANCA-Associated Glomerulonephritis.
    Aendekerk JP, Timmermans SAMEG, Busch MH, Potjewijd J, Heeringa P, Damoiseaux JGMC, Reutelingsperger CP, van Paassen P, Limburg Renal Registry.
    Clin J Am Soc Nephrol; 2020 Dec 07; 15(12):1740-1748. PubMed ID: 33203735
    [Abstract] [Full Text] [Related]

  • 9. Increased Urinary CD163 Levels in Systemic Vasculitis with Renal Involvement.
    Aierken X, Zhu Q, Wu T, Liu SS, Cao YY, Cai XT, Aihemaiti A, Bi Y, Yang S, Zhang W, Li N.
    Biomed Res Int; 2021 Dec 07; 2021():6637235. PubMed ID: 33997033
    [Abstract] [Full Text] [Related]

  • 10. Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis.
    Mejia-Vilet JM, Zhang XL, Cruz C, Cano-Verduzco ML, Shapiro JP, Nagaraja HN, Morales-Buenrostro LE, Rovin BH.
    J Am Soc Nephrol; 2020 Jun 07; 31(6):1335-1347. PubMed ID: 32300067
    [Abstract] [Full Text] [Related]

  • 11. Urinary soluble CD163 is a putative non-invasive biomarker for primary sclerosing cholangitis.
    Elger T, Fererberger T, Huss M, Sommersberger S, Mester P, Stoeckert P, Gunawan S, Liebisch G, Loibl J, Kandulski A, Müller M, Buechler C, Tews HC.
    Exp Mol Pathol; 2024 Jun 07; 137():104900. PubMed ID: 38729058
    [Abstract] [Full Text] [Related]

  • 12. Urine soluble CD163 (sCD163) as biomarker in glomerulonephritis: stability, reference interval and diagnostic performance.
    Nielsen AJ, Nielsen MC, Birn H, Ivarsen P, Møller HJ, Hviid CVB.
    Clin Chem Lab Med; 2021 Mar 26; 59(4):701-709. PubMed ID: 33068375
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic value of urine sCD163 levels for sepsis and relevant acute kidney injury: a prospective study.
    Su L, Feng L, Liu C, Jiang Z, Li M, Xiao K, Yan P, Jia Y, Feng D, Xie L.
    BMC Nephrol; 2012 Sep 26; 13():123. PubMed ID: 23013330
    [Abstract] [Full Text] [Related]

  • 14. Urinary soluble CD163 is a good biomarker for renal disease activity in lupus nephritis.
    Gupta R, Yadav A, Aggarwal A.
    Clin Rheumatol; 2021 Mar 26; 40(3):941-948. PubMed ID: 32809146
    [Abstract] [Full Text] [Related]

  • 15. Clinical impact of urinary CD11b and CD163 on the renal outcomes of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
    Yokoe Y, Tsuboi N, Imaizumi T, Kitagawa A, Karasawa M, Ozeki T, Endo N, Sawa Y, Kato S, Katsuno T, Maruyama S, Yamagata K, Usui J, Nagata M, Sada KE, Sugiyama H, Amano K, Arimura Y, Atsumi T, Yuzawa Y, Dobashi H, Takasaki Y, Harigai M, Hasegawa H, Makino H, Matsuo S, Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis and for Intractable Renal Disease.
    Nephrol Dial Transplant; 2021 Jul 23; 36(8):1452-1463. PubMed ID: 32639002
    [Abstract] [Full Text] [Related]

  • 16. Soluble CD163 as a Potential Biomarker in Systemic Sclerosis.
    Frantz C, Pezet S, Avouac J, Allanore Y.
    Dis Markers; 2018 Jul 23; 2018():8509583. PubMed ID: 29805720
    [Abstract] [Full Text] [Related]

  • 17. Serum levels of the soluble haemoglobin scavenger receptor CD163 in MPO-ANCA-associated renal vasculitis.
    Nagai M, Hirayama K, Ebihara I, Higuchi T, Shimohata H, Kobayashi M.
    Scand J Rheumatol; 2016 Oct 23; 45(5):397-403. PubMed ID: 27094919
    [Abstract] [Full Text] [Related]

  • 18. Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
    Andersen MN, Abildgaard N, Maniecki MB, Møller HJ, Andersen NF.
    Eur J Haematol; 2014 Jul 23; 93(1):41-7. PubMed ID: 24612259
    [Abstract] [Full Text] [Related]

  • 19. Soluble Scavenger Receptor CD163 Is Associated with Severe Acute Kidney Injury in Patients with Hantaan Virus Infection.
    Zhang Y, Ma Y, Zhang C, Zhang Y, Zhuang R, Liu B, Yi J, Jin B.
    Viral Immunol; 2015 May 23; 28(4):241-6. PubMed ID: 25789628
    [Abstract] [Full Text] [Related]

  • 20. Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus.
    Nishino A, Katsumata Y, Kawasumi H, Hirahara S, Kawaguchi Y, Yamanaka H.
    Lupus; 2019 Jul 23; 28(8):986-994. PubMed ID: 31246559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.